Gene · 23523
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liver transplantation-related osteoporosis and fragility fractures: pathogenic pathways, risk stratification and novel targeted therapy advances. | Front Immunol | 2026 | 42825020 | PubTator, text mining | PubMed |
| Maintenance of Minimal Manifestation Status with Individualized-Interval Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial. | Neurol Ther | 2026 | 42786372 | PubTator, text mining | PubMed |
| Reply: Chronic kidney disease after liver transplantation: Accurate measurement, early acute kidney injury, and renal-protective strategies. | World J Transplant | 2026 | 42751273 | PubTator, text mining | PubMed |
| Conversion From Calcineurin Inhibitor to Ruxolitinib as GVHD Prophylaxis During Patients With Transplant-Associated Thrombotic Microangiopathy. | Transplant Cell Ther | 2026 | 42749189 | PubTator, text mining | PubMed |
| Alcohol-Triggered Periocular Flushing Associated With Tacrolimus 0.1% Ophthalmic Solution in Sjögren-Related Ocular Surface Disease. | Cornea | 2026 | 42746853 | PubTator, text mining | PubMed |
| Associations of IL-2, IL-6 and IL-10 Gene Polymorphisms with Biochemical Parameters and Calcineurin Inhibitor Dosing in Kidney Transplant Recipients. | Biomedicines | 2026 | 42652239 | PubTator, text mining | PubMed |
| Urinary HSP90 as a non-invasive biomarker of active tubular injury in kidney transplant recipients: A multicenter prospective study. | Cell Stress Chaperones | 2026 | 42648627 | PubTator, text mining | PubMed |
| Authors' Reply: Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with Sodium-Glucose Cotransporter 2 Inhibition in Kidney Transplant Recipients? | Clin J Am Soc Nephrol | 2026 | 42584954 | PubTator, text mining | PubMed |
| Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with SGLT2 Inhibition in Kidney Transplant Recipients? | Clin J Am Soc Nephrol | 2026 | 42584943 | PubTator, text mining | PubMed |
| Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report. | Case Rep Oncol | 2026 | 42569788 | PubTator, text mining | PubMed |
| Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial. | Lancet Haematol | 2026 | 42532067 | PubTator, text mining | PubMed |
| Histopathology-Paired Clinical Improvement Following Topical Rosa damascena-Derived Exosomes in Long-Standing Refractory Male Genital Lichen Planus: A Single-Patient Case Report. | Pharmaceuticals (Basel) | 2026 | 42515694 | PubTator, text mining | PubMed |
| Regulatory T cell modulation with selective CD28 blockade and IL-6 receptor antagonist in kidney transplant recipients: Results of CTOT-24-a prospective clinical trial. | Am J Transplant | 2026 | 42486389 | PubTator, text mining | PubMed |
| Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis. | Sci Rep | 2026 | 42477014 | PubTator, text mining | PubMed |
| Hypogammaglobulinemia and B cell repopulation after rituximab in childhood nephrotic syndrome. | Pediatr Nephrol | 2026 | 42435047 | PubTator, text mining | PubMed |
| Cannabis use and Post-Transplant Outcomes in Heart Transplant Recipients: A Propensity-Matched Cohort Study. | Clin Transplant | 2026 | 42406563 | PubTator, text mining | PubMed |
| Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation. | JCO Oncol Pract | 2026 | 42372210 | PubTator, text mining | PubMed |
| Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances. | Front Pharmacol | 2026 | 42371577 | PubTator, text mining | PubMed |
| [Efficacy and safety of rituximab in children with refractory nephrotic syndrome]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | 42305001 | PubTator, text mining | PubMed |
| Overlap of PR3-Positive ANCA-Associated Vasculitis and Primary Focal Segmental Glomerulosclerosis: A Case Report, Patient Perspective, and Review of the Literature. | Can J Kidney Health Dis | 2026 | 42293166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23523/papers